Medicine
Fludeoxyglucose f-18 300 mCi/mL injection
Fludeoxyglucose f-18 300 mCi/mL injection is a generic prescription medicine for intravenous use, made by 14 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store the Fludeoxyglucose F 18 Injection vial upright in a lead shielded…
Key facts
- Active ingredient (INN)
- Fludeoxyglucose f-18
- Brand
- Sold under the generic name
- Strength
- 300 mCi/mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 30 mL, 10 mL, 50 mL and 13 more
- Manufacturers
- Jubilant RadiopharmaIndia3D Imaging Drug Design and DevelopmentSofieBarbara Ann Karmanos Cancer HospitalBiomedical Research Foundation of Northwest LouisianaBrigham and Women's Hospital, Inc., TheCyclotron Radiochemistry Lab / Huntsman Cancer InstituteMassachusetts General HospitalMIPS Cyclotron & Radiochemistry FacilityThe Regents of the University of Michigan
- Origin register
- US FDA, United States
- Storage
- Store the Fludeoxyglucose F 18 Injection vial upright in a lead shielded container at 25°C (77°F), excursions permitted to 15-30°C (59-86°F). Store and dispose of Fludeoxyglucose F 18 Injection in accordance with the regulations and a general license, or its equivalent, of an Agreement State or a Licensing State.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V09IX04 Fludeoxyglucose f-18
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 November 2010
- Identifiers
- DailyMed set ID 2785ce60-86c9-42c2-ab0a-8c5d5adf60d3, 232fbb91-402e-44d8-a0cf-6813980b8ead, 5d05df4a-463e-4e66-9387-f3a842e20cd0 +11NDC 76451-118, 76318-334, 60055-334 +11Application ANDA203778, ANDA204333, ANDA203920 +11
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 mL in 1 vial | 60055-334-30 | Jubilant RadiopharmaIndia | 1 September 2015 |
| 10 mL in 1 vial, glass | 76451-118-10 | 3D Imaging Drug Design and Development | 17 December 2018 |
| 30 mL in 1 vial, glass | 76451-118-30 | 3D Imaging Drug Design and Development | 17 December 2018 |
| 30 mL in 1 vial, glass | 78714-001-30 | Barbara Ann Karmanos Cancer Hospital | 31 January 2020 |
| 30 mL in 1 vial, glass | 24562-001-30 | Biomedical Research Foundation of Northwest Louisiana | 14 May 2015 |
| 30 mL in 1 vial, multi-dose | 24450-647-30 | Brigham and Women`s Hospital, Inc., the | 30 October 2014 |
| 50 mL in 1 vial, multi-dose | 67939-010-50 | Cyclotron Radiochemistry Lab / Huntsman Cancer Institute | 20 May 2020 |
| 50 mL in 1 vial | 76318-334-50 | Massachusetts General Hospital | 30 October 2011 |
| 30 mL in 1 vial, glass | 69587-001-01 | MIPS Cyclotron & Radiochemistry Facility | 21 December 2018 |
| 19 mL in 1 vial, glass | 76326-001-20 | The Regents of the University of Michigan | 17 July 2015 |
| 30 mL in 1 vial, multi-dose | 49609-101-01 | Sofie | 8 December 2011 |
| 50 mL in 1 vial, multi-dose | 49609-101-02 | Sofie | 8 December 2011 |
| 17 mL in 1 vial, glass | 24275-0185-1 | UCSF Radiopharmaceutical Facility | 2 January 2013 |
| 30 mL in 1 vial, glass | 24417-001-30 | Uihc-P E T Imaging Center | 12 December 2011 |
| 27 mL in 1 vial, glass | 60215-411-30 | The University of Texas MD Anderson Cancer Center | 6 December 2011 |
| 30 mL in 1 vial, glass | 75913-647-30 | Washington University School of Medicine | 2 January 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 August 1994 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Fludeoxyglucose f-18 300 mCi/mL injection.
Other strengths and forms of Fludeoxyglucose f-18
Clinical summary
Fludeoxyglucose f-18 is a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging in settings, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Fludeoxyglucose f-18 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Fludeoxyglucose f-18For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Fludeoxyglucose F18 prescribing information (The Feinstein Institute for Medical Research) · U.S. National Library of Medicine, DailyMed
Need Fludeoxyglucose f-18 300 mCi/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.